Enhancement of bioavailability by lowering of fat content in topical formulations

British Journal of Dermatology

Volumn 160, Issue 3, 2009, Pages 552-556

  Wiren K ^a   Frithiof, H ^b   Sjoqvist C ^b   Loden M ^a  

^a Research and Development   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Benzyl nicotinate; Blanching; Corticosteroids; Emulsion; Erythema

Indexed keywords

BENZYL NICOTINATE; BETAMETHASONE VALERATE; COSMETIC;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG FORMULATION; ERYTHEMA; FAT CONTENT; FEMALE; HUMAN; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN COLOR; SKIN PENETRATION;

ADMINISTRATION, CUTANEOUS; ADULT; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DERMATOLOGIC AGENTS; EMULSIONS; FATS; FEMALE; HUMANS; MALE; NICOTINIC ACIDS; OINTMENTS; SKIN; SKIN ABSORPTION; SKIN PIGMENTATION; VASOCONSTRICTION; YOUNG ADULT;

EID: 60449083341     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08981.x     Document Type: Article

References (20)

1. Serup J, Lindblad AK, Maroti M et al. To follow or not to follow dermatological treatment - a review of the literature. Acta Derm Venereol (Stockh) 2006 86 : 193 7.
2. Diffey BL, Grice J. The influence of sunscreen type on photoprotection. Br J Dermatol 1997 137 : 103 5.
3. Ivens UI, Steinkjer B, Serup J et al. Ointment is evenly spread on the skin, in contrast to creams and solutions. Br J Dermatol 2001 145 : 264 7.
4. Lynfield YL, Schechter BA. Choosing and using a vehicle. J Am Acad Dermatol 1984 10 : 56 9.
5. Lodén M, Buraczewska I, Halvarsson K. Facial anti-wrinkle cream: influence of product presentation on effectiveness: a randomized and controlled study. Skin Res Technol 2007 13 : 189 94.
6. Ali SM, Brodell RT, Balkrishnan R et al. Poor adherence to treatments: a fundamental principle of dermatology. Arch Dermatol 2007 143 : 912 15.
7. Surber C, Smith EW. The mystical effects of dermatological vehicles. Dermatology 2005 210 : 157 68.
8. Berth-Jones J, Damstra RJ, Golsch S et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ 2003 326 : 1367.
9. Smith EW, Meyer E, Haigh JM. Blanching activities of betamethasone formulations. The effect of dosage form on topical drug availability. Arzneimittelforschung 1990 40 : 618 21.
10. O'Doherty J, Henricson J, Anderson C et al. Sub-epidermal imaging using polarized light spectroscopy for assessment of skin microcirculation. Skin Res Technol 2007 13 : 472 84.
11. Oestmann E, Lavrijsen AP, Hermans J et al. Skin barrier function in healthy volunteers as assessed by transepidermal water loss and vascular response to hexyl nicotinate: intra- and inter-individual variability. Br J Dermatol 1993 128 : 130 6.
12. Lavrijsen AP, Oestmann E, Hermans J et al. Barrier function parameters in various keratinization disorders: transepidermal water loss and vascular response to hexyl nicotinate. Br J Dermatol 1993 129 : 547 53.
13. Seidenari S, Di Nardo A, Mantovani L et al. Parallel intraindividual evaluation of the vasoconstrictory action and the anti-allergic activity of topical corticosteroids. Exp Dermatol 1997 6 : 75 80.
14. Remane Y, Leopold CS. Time of erythema onset after application of methyl nicotinate ointments as response parameter: influence of penetration kinetics and enhancing agents. Skin Pharmacol Physiol 2006 19 : 303 10.
15. Roskos KV, Bircher AJ, Maibach HI, Guy RH. Pharmacodynamic measurements of methyl nicotinate percutaneous absorption: the effect of aging on microcirculation. Br J Dermatol 1990 122 : 165 71.
16. Higuchi T. Physical chemical analysis of percutaneous absorption process from creams and ointments. J Soc Cosmet Chem 1960 11 : 85 97.
17. Sahlin A, Edlund F, Lodén M. A double-blind and controlled study on the influence of the vehicle on the skin susceptibility to stinging from lactic acid. Int J Cosmet Sci 2007 29 : 385 90.
18. Lalor CB, Flynn GL, Weiner N. Formulation factors affecting release of drug from topical formulations. 1. Effect of emulsion type upon in vitro delivery of ethyl p-aminobenzoate. J Pharm Sci 1994 83 : 1525 8.
19. Izquierdo P, Wiechers JW, Escribano E et al. A study on the influence of emulsion droplet size on the skin penetration of tetracaine. Skin Pharmacol Physiol 2007 20 : 263 70.
20. Coldman MF, Poulsen BJ, Higuchi T. Enhancement of percutaneous absorption by the use of volatile: nonvolatile systems as vehicles. J Pharm Sci 1969 58 : 1098 102.